Evidence map›Paper›PMID 27891352›Full record

ArticleJournal of clinical and diagnostic research : JCDR2016

Herbal Fixed Dose Combinations in Nepal: Growing Concerns in a Developing Country.

Arjun Poudel, Kadir Alam, Subish Palaian, Mohamed Izham Mohamed Ibrahim

Abstract read
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arjun PoudelResearch Associate, School of Clinical Sciences, Faculty of Health, Queensland University of Technology , Brisbane, Australia .
Kadir AlamAssociate Professor, Department of Clinical Pharmacology and Therapeutics, B.P. Koirala Institute of Health Sciences , Dharan, Nepal .
Subish PalaianAssociate Professor, Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University , Ajman, United Arab Emirates .
Mohamed Izham Mohamed IbrahimProfessor, Department of Social and Administrative Pharmacy, College of Pharmacy, Qatar University , Doha, Qatar .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal medicines are mostly prepared as a combination therapy that has been used since therapeutic was first practiced. Combination products, also known as Fixed Dose Combinations (FDCs) of herbal remedies are in widespread use in Nepal. Herbal FDCs are in common practice because it is believed to have better adherence, less side effects and easy accessibility. Nevertheless, combination products possess greater risk of adverse effects, increases costs associated with treatments and leads to an ineffective dosages. Herbal FDCs are used extensively in Nepal although the rationality beyond the use of these combinations is still unidentified and at times are questionable. Legislations governing the use of herbal medicines is lacking in Nepal. Many herbal FDCs are not supported by any scientific data and test for the presence of ingredients mentioned in the package insert/container label is always difficult. A FDC of herbal products must be based on clear criteria that guarantee consumer safety and appropriate indications. These criteria helps to protect the consumers or patients from the misleading claims and risk associated with the use of unjustifiable combination of herbal substances. Strict monitoring from the regulatory body and the public awareness on the cost as well as advantages and disadvantages of herbal FDCs is urgently required.

Indexed as

Combination therapyHerbal medicinesIrrational drug use

Identifiers

PMID27891352
PMCPMC5121690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.